These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26541778)

  • 41. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.
    Aghevlian S; Wu B; Raie MN; Tumbale SK; Kare AJ; Seo JW; Ferrara KW
    Nucl Med Biol; 2021; 98-99():8-17. PubMed ID: 33962357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
    Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
    J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
    Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
    Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
    Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W
    PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.
    Liu S; Li D; Guo J; Canale N; Li X; Liu R; Krasnoperov V; Gill PS; Conti PS; Shan H; Li Z
    Mol Pharm; 2014 Nov; 11(11):3974-9. PubMed ID: 24978094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
    Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
    Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
    Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.
    Zhang Y; Hong H; Orbay H; Valdovinos HF; Nayak TR; Theuer CP; Barnhart TE; Cai W
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):759-67. PubMed ID: 23344138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
    Yamaguchi A; Achmad A; Hanaoka H; Heryanto YD; Bhattarai A; Ratianto ; Khongorzul E; Shintawati R; Kartamihardja AAP; Kanai A; Sugo Y; S Ishioka N; Higuchi T; Tsushima Y
    BMC Cancer; 2019 Oct; 19(1):1000. PubMed ID: 31651282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
    Wang H; Li D; Liu S; Liu R; Yuan H; Krasnoperov V; Shan H; Conti PS; Gill PS; Li Z
    J Nucl Med; 2015 Jun; 56(6):908-13. PubMed ID: 25908833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer.
    Li J; Zheng H; Bates PJ; Malik T; Li XF; Trent JO; Ng CK
    Nucl Med Biol; 2014 Feb; 41(2):179-85. PubMed ID: 24373858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice.
    Cai W; Ebrahimnejad A; Chen K; Cao Q; Li ZB; Tice DA; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2024-36. PubMed ID: 17673999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.
    Liu S; Li D; Park R; Liu R; Xia Z; Guo J; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
    J Nucl Med; 2013 Jul; 54(7):1094-100. PubMed ID: 23667241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A vascular endothelial growth factor 121 (VEGF(121))-based dual PET/optical probe for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Lee KC; Choe YS; Choi JY; Lee KH; Kim BT
    Biomaterials; 2013 Sep; 34(28):6839-45. PubMed ID: 23787114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.